MARTORANA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 28.101
EU - Europa 1.849
AS - Asia 471
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
AF - Africa 5
Totale 30.461
Nazione #
US - Stati Uniti d'America 28.086
UA - Ucraina 382
DE - Germania 329
IE - Irlanda 298
IT - Italia 279
CN - Cina 267
FR - Francia 131
KR - Corea 131
GB - Regno Unito 101
SE - Svezia 90
FI - Finlandia 73
PL - Polonia 65
RU - Federazione Russa 47
BE - Belgio 15
JP - Giappone 14
KG - Kirghizistan 14
NL - Olanda 13
CA - Canada 12
EU - Europa 12
ES - Italia 9
IN - India 9
BR - Brasile 7
AU - Australia 5
CL - Cile 5
SG - Singapore 5
TR - Turchia 5
CH - Svizzera 4
GR - Grecia 4
CG - Congo 3
HK - Hong Kong 3
NO - Norvegia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AR - Argentina 2
AT - Austria 2
DM - Dominica 2
IL - Israele 2
MY - Malesia 2
NG - Nigeria 2
PH - Filippine 2
SA - Arabia Saudita 2
VN - Vietnam 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
Totale 30.461
Città #
Woodbridge 8.140
Wilmington 7.430
Houston 7.179
Fairfield 1.082
Ann Arbor 685
Chandler 465
Ashburn 452
Seattle 433
Cambridge 347
Jacksonville 333
Dublin 278
Medford 221
Dearborn 211
Beijing 123
New York 119
Lawrence 104
Rome 100
Kraków 62
San Diego 60
Mülheim 51
Menlo Park 44
Zhengzhou 41
Norwalk 29
Milan 28
Palo Alto 28
Redwood City 20
London 19
Hangzhou 16
Brussels 15
Falls Church 13
University Park 13
Hefei 12
Seoul 12
Shanghai 12
Saint Petersburg 11
Verona 11
Del Norte 10
Toronto 10
Mountain View 9
San Mateo 8
Kilburn 7
Nanjing 7
Center 6
Chicago 6
Detroit 6
Ferrara 6
Fuzhou 6
Guangzhou 6
Madrid 6
Miami 6
Monmouth Junction 6
Amsterdam 5
Atlanta 5
Bologna 5
Nürnberg 5
Phoenix 5
Brasília 4
Hebei 4
Pirri 4
San Jose 4
Stafford 4
Tokyo 4
Agrigento 3
Auburn Hills 3
Bielefeld 3
Boardman 3
Brazzaville 3
Changsha 3
Chester 3
Chongqing 3
Florence 3
Hounslow 3
Indiana 3
Jinan 3
Nanchang 3
Redmond 3
San Francisco 3
Taipei 3
Torre Annunziata 3
Atripalda 2
Brescia 2
Chengdu 2
Cologne 2
Dong Ket 2
Engelhard 2
Groningen 2
Helsinki 2
Hyderabad 2
Islington 2
Istanbul 2
Kunming 2
Kwun Hang 2
Latina 2
Lausanne 2
Liverpool 2
Los Angeles 2
Manila 2
Martinez 2
Mcallen 2
Midoricho 2
Totale 28.446
Nome #
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 455
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 436
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 434
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. 432
Transient global amnesia: linked to a systemic disorder of amino acid catabolism? 432
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 427
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 424
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 418
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 414
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 412
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain 408
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 408
Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients 407
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 404
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry 403
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 401
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. 401
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients 401
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 394
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex 392
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" 392
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 391
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? 391
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease 390
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 389
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 387
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 387
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 386
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? 384
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene 383
Huntingtin distribution among striatal output neurons of normal rat brain 383
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. 383
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 381
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 381
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 381
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 377
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 376
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients 375
Tissue plasminogen activator is required for corticostriatal long-term potentiation 374
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 374
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 372
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 371
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study 370
Plasmin system of Alzheimer's disease patients: CSF analysis 369
Reversal of LTP-Like cortical plasticity in Alzheimer's disease patients with tau-related faster clinical progression 369
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 368
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins 367
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 367
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 364
Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients 364
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. 361
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra 359
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 358
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 351
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 350
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities 350
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 349
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 348
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? 343
Frailty among Alzheimer's disease patients 342
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 339
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 338
Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle 331
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 329
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? 326
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension 324
Is dopamine involved in Alzheimer's disease? 323
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients 319
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 319
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients 318
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients. 313
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 299
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 287
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity 271
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 251
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 248
Assessment of serum uric acid as risk factor for tauopathies 243
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 231
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 169
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 145
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 140
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 139
Alzheimer’s disease and the routine clinical use of CSF biomarkers 137
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 119
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 105
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 104
Insulin and the future treatment of Alzheimer’s disease 102
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 102
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 101
Ageing as a Trait de Union between diabetes and dementia for frailty 96
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State 91
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 88
Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease 83
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 52
Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients? 47
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 47
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 45
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 40
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 38
Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: rationale, noninvasive brain stimulation protocol, and study design 34
Totale 30.593
Categoria #
all - tutte 56.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.807 0 0 0 0 0 0 0 0 0 0 941 866
2019/20208.397 732 715 519 771 769 902 747 750 713 700 513 566
2020/20215.342 718 658 582 700 569 531 614 514 107 124 183 42
2021/20221.188 61 159 88 37 32 116 55 90 71 81 75 323
2022/20231.293 146 111 45 131 100 301 111 58 114 16 109 51
2023/2024407 58 16 31 25 42 150 21 44 10 10 0 0
Totale 30.804